Crossmark

A new strategy for melanoma treatment: an investigation of the clinical value of the combination of immune checkpoint inhibitors and oncolytic viruses

Crossref DOI link: https://doi.org/10.1186/s12935-025-04143-9

Published Online: 2025-12-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sui, Bei

Jin, Xuyin

Zheng, Xiaowei
Funding

Funding for this research was provided by:

Medical and Health Science and Technology Program of Zhejiang Province (2023KY521)

Zhejiang health high-level talents medical rookie (Zhejiang Health Office (2022) No. 32)
License Information

Text and Data Mining valid from 2025-12-26

Version of Record valid from 2026-01-22
More Information

Article History

Received: 2 July 2025

Accepted: 17 December 2025

First Online: 26 December 2025

Declarations

:

: The authors declare no competing interests.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below